Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Exploring the Antiviral Mechanism of NK cells against HSV-2

EF 2011-12

Résumé
Herpes simplex virus type 2 (HSV-2) is one of the most prevalent sexually transmitted infections across the globe. As the main cause of genital herpes, it presents a large burden on the health care system. Furthermore, it has been implicated in the infection, transmission, and disease progression of human immunodeficiency virus (HIV), a deadly chronic viral infection with no known cure. Therefore, it is imperative to develop an effective vaccine and treatment strategy against HSV-2. We are investigating a specific immune response responsible for controlling early HSV-2 infection. Natural killer (NK) cells are immune cells that respond rapidly to HSV-2 infection and are a key element in controlling the early stages of infection. The methods of activating these NK cells against HSV-2 and how they control infection are not fully known. Interleukin-15 and type I interferon are immune components produced by our bodies that initiate an immune response against viral infection. In the case of HSV-2, these components appear to be necessary for the activation and function of NK cells against HSV-2 infection. Once the NK cells are activated, there is evidence suggesting that they can then increase the production of nitric oxide (a multi-functional molecule that is produced by the body; NO) at the site of infection. Increased production of NO may prevent the virus from reproducing, which can limit the symptoms and spread of HSV-2. In determining the existence of this specific immune response, we can develop therapies based on enhancing this process to prevent or control HSV-2 infection. If we can minimize the symptoms and spread of HSV-2, we will be able to improve the quality of life of those living with genital herpes, thereby lowering the HSV-2 related burden on the healthcare system. Furthermore, a treatment for HSV-2 could lower the rate of HIV transmission and improve the outcome for those who are currently infected with HIV.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
253333
Name
Lee Amanda J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Exploring the Antiviral Mechanism of NK cells against HSV-2
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Handling; Elisas; Flow Cytometry; Herpes Simplex Virus Type 2; Interferons; Interleukin-15; Natural Killer Cells; Nitric Oxide; Viral Titering
Abstract
Herpes simplex virus type 2 (HSV-2) is one of the most prevalent sexually transmitted infections across the globe. As the main cause of genital herpes, it presents a large burden on the health care system. Furthermore, it has been implicated in the infection, transmission, and disease progression of human immunodeficiency virus (HIV), a deadly chronic viral infection with no known cure. Therefore, it is imperative to develop an effective vaccine and treatment strategy against HSV-2. We are investigating a specific immune response responsible for controlling early HSV-2 infection. Natural killer (NK) cells are immune cells that respond rapidly to HSV-2 infection and are a key element in controlling the early stages of infection. The methods of activating these NK cells against HSV-2 and how they control infection are not fully known. Interleukin-15 and type I interferon are immune components produced by our bodies that initiate an immune response against viral infection. In the case of HSV-2, these components appear to be necessary for the activation and function of NK cells against HSV-2 infection. Once the NK cells are activated, there is evidence suggesting that they can then increase the production of nitric oxide (a multi-functional molecule that is produced by the body; NO) at the site of infection. Increased production of NO may prevent the virus from reproducing, which can limit the symptoms and spread of HSV-2. In determining the existence of this specific immune response, we can develop therapies based on enhancing this process to prevent or control HSV-2 infection. If we can minimize the symptoms and spread of HSV-2, we will be able to improve the quality of life of those living with genital herpes, thereby lowering the HSV-2 related burden on the healthcare system. Furthermore, a treatment for HSV-2 could lower the rate of HIV transmission and improve the outcome for those who are currently infected with HIV.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lee, Amanda J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~